← Top stories
● Neutral for Indian equities
Merck's drug for diabetes-related eye disease meets trial goal
- Fortis says independent audit will establish non-involvement in Singh brothers’ share transfers
- Fortis confident of clean chit from audit in Singh brothers’ dispute
- Supreme Court allows independent forensic audit of Fortis transactions in Daiichi dispute
- Regulator mulls digital platform for drugmakers' test reports
- Mint Explainer | Why NHRC wants India’s drugs regulator to build a national digital registry